Clinical Trials Logo
  1. Home
  2. Sjögren Syndrome
  3. NCT02132585

Cross-sectional Study of Use of Speckle Method in Early Diagnosis of Cardiovascular Dysfunction — SPEEDCARS  

Sjogren Syndrome Clinical Trial

Official title:
Cross Sectional Study of Use of Speckle Tracking Echocardiography in the Early Diagnosis of Cardiovascular Dysfunction and Performance in Sjogren Patients

Clinical Trial Summary

Speckle tracking (STE) is a novel echocardiographic technique which permits calculation of myocardial velocities and deformation parameters such as strain and strain rate (SR). It is demonstrated that these parameters provide important insights into systolic and diastolic function, ischaemia, myocardial mechanics and many other pathophysiological processes of the heart. In this preliminary study, we investigated the role of STE in detection of early ventricular dysfunction in patients with Sjogren Syndrome, focusing on cardiorespiratory fitness.

Clinical Trial Description

n/a

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02132585
Study type Observational
Source University of Roma La Sapienza
Contact
Status Active, not recruiting
Phase N/A
Start date January 2010
Completion date May 2014
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03839069 - Minor Salivary Gland Transplantation for Cicatrizing Conjunctivitis N/A
Completed NCT03865888 - Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome Phase 3
Terminated NCT04988087 - A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD) Phase 2
Completed NCT02257957 - Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye Phase 3
Completed NCT01647737 - Green Tea Lozenges for the Management of Dry Mouth Phase 1/Phase 2
Recruiting NCT02450396 - Pregnancy and Medically Assisted Conception in Rare Diseases
Recruiting NCT05350072 - Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome Phase 3
Active, not recruiting NCT05124925 - Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments. Phase 2
Recruiting NCT03816345 - Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer Phase 1
Completed NCT01850979 - Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops Phase 4
Recruiting NCT05349214 - Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome Phase 3